Showing 361 - 380 results of 3,138 for search '"Intestine"', query time: 0.08s Refine Results
  1. 361
  2. 362

    SAA3 deficiency exacerbates intestinal fibrosis in DSS-induced IBD mouse model by Xiaodong Zou, Tong Wu, Jianjiao Lin, Tao Su, Hui Xiao, Chuyan Ni, Lijuan Hu, Wenchu Lin, Weilin Chen, Richard D. Ye, Li Xiang

    Published 2025-01-01
    “…Abstract Intestinal fibrosis, as a late-stage complication of inflammatory bowel disease (IBD), leads to bowel obstruction and requires surgical intervention, significantly lowering the quality of life of affected patients. …”
    Get full text
    Article
  3. 363
  4. 364
  5. 365

    Helicobacter pylori CagA+ strains modulate colorectal pathology by regulating intestinal flora by Shasha Cui, Xinqiang Liu, Fengxia Han, Lu Zhang, Jingjing Bu, Sainan Wu, Jiafen Wang

    Published 2025-02-01
    “…Conclusion HP CagA+ strains are capable of causing gut microbiota dysbiosis to develop destruction of intestinal barrier, and it may affect the development of colorectal cancer by increasing colonization of Staphylococcus and Corynebacterium.…”
    Get full text
    Article
  6. 366
  7. 367

    Loss of Notch dimerization perturbs intestinal homeostasis by a mechanism involving HDAC activity. by Quanhui Dai, Kristina Preusse, Danni Yu, Rhett A Kovall, Konrad Thorner, Xinhua Lin, Raphael Kopan

    Published 2024-12-01
    “…To ask if HDAC2 activity contributes to Notch loss-of-function phenotypes, we used the HDAC2 inhibitor Valproic acid (VPA) and discovered it could prevent the intestinal consequences of NDD and gamma secretase inhibitors (DBZ or DAPT) treatment in mice and spheroids, suggesting synergy between HDAC activity and pro-differentiation program in intestinal stem cells.…”
    Get full text
    Article
  8. 368
  9. 369

    A Curious Case of Intestinal Diaphragm Disease Unmasked by Perforation of a Duodenal Ulcer by Mairéad McNally, Ion Cretu

    Published 2017-01-01
    “…Nonsteroidal anti-inflammatory drugs are a common cause of intestinal injury. A variety of NSAID-induced injuries may occur including ulcers, erosions, colitis, strictures, and diaphragm disease. …”
    Get full text
    Article
  10. 370
  11. 371
  12. 372

    Gastric Intestinal Metaplasia: Demographic and Epidemiological Characterization in Puerto Rican Hispanics (2012-2014) by Jorge J. Cruz-Cruz, María González-Pons, Adrián Cora-Morges, Marievelisse Soto-Salgado, Giancarlo Colón, Kimberly Alicea, Kathia Rosado, Douglas R. Morgan, Marcia Cruz-Correa

    Published 2021-01-01
    “…Helicobacter pylori is the most common chronic bacterial infection in humans and the major predisposing factor for the development of gastric intestinal metaplasia (GIM), the principal preneoplastic lesion in the gastric carcinogenesis pathway. …”
    Get full text
    Article
  13. 373

    Sleep Quality and Levodopa Intestinal Gel Infusion in Parkinson’s Disease: A Pilot Study by Oriol De Fabregues, Alex Ferré, Odile Romero, Manuel Quintana, José Álvarez-Sabin

    Published 2018-01-01
    “…To assess the effect of levodopa-carbidopa intestinal gel (LCIG) infusion on sleep quality in advanced PD patients. …”
    Get full text
    Article
  14. 374
  15. 375

    IL-22 mediates goblet cell hyperplasia and worm expulsion in intestinal helminth infection. by Jan-Eric Turner, Brigitta Stockinger, Helena Helmby

    Published 2013-01-01
    “…Type 2 immune responses are essential in protection against intestinal helminth infections. In this study we show that IL-22, a cytokine important in defence against bacterial infections in the intestinal tract, is also a critical mediator of anti-helminth immunity. …”
    Get full text
    Article
  16. 376
  17. 377
  18. 378

    Detection of genetic determinants of potentially oncogenic representatives of the intestinal microbiota as biomarkers of colorectal cancer by Viktoriya N. Shumilova, Artemij E. Goncharov, Daniil V. Azarov, Stanislav I. Sitkin, Elgudzha L. Latariya, Batyrbek I. Aslanov, Mikhail A. Bobrakov, Rustem E. Topuzov

    Published 2024-11-01
    “…The aim of this study was to evaluate the possibility of using genetic determinants of potentially oncogenic microorganisms as markers for colorectal cancer, based on a comparison of their prevalence in groups of patients with colorectal cancer, facultative precancerous diseases and patients without intestinal pathology. Materials and methods. 215 participants were included in the "case–control" study: 70 patients with newly diagnosed colorectal cancer, 70 patients with inflammatory bowel disease, 75 participants without diagnosed intestinal pathology. …”
    Get full text
    Article
  19. 379

    An Assessment of the Intestinal Lumen as a Site for Intervention in Reducing Body Burdens of Organochlorine Compounds by Ronald J. Jandacek, Stephen J. Genuis

    Published 2013-01-01
    “…While dietary fat facilitates the absorption of OCs from the small intestine, it has little effect on OCs within the large intestine. …”
    Get full text
    Article
  20. 380

    Intestinal inflammation in TNBS sensitized rats as a model of chronic inflammatory bowel disease by N. Selve, T. Wöhrmann

    Published 1992-01-01
    “…This treatment induced chronic inflammation of the distal small intestine characterized by intense hyperaemia, oedema and gut wall thickening as assessed by macroscopic scoring and weighing a defined part of the dissected intestine. …”
    Get full text
    Article